Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Minority Interest (2020 - 2021)

GeneDx Holdings (WGS) has disclosed Minority Interest for 2 consecutive years, with $294.7 million as the latest value for Q1 2021.

  • On a quarterly basis, Minority Interest changed N/A to $294.7 million in Q1 2021 year-over-year; TTM through Mar 2021 was $294.7 million, a N/A change, with the full-year FY2020 number at $353.2 million, changed N/A from a year prior.
  • Minority Interest was $294.7 million for Q1 2021 at GeneDx Holdings, down from $353.2 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $353.2 million in Q4 2020 to a low of $294.7 million in Q1 2021.